(1)
Review at a convened
meeting. Except when an expedited review procedure is used, per (d), the
DHSIRB performs an initial review of proposed new research projects at a
convened meeting when a quorum is present. In order for the research to be
approved, it must receive the approval of a majority of those members present
at the meeting.
(2)
Reliance
on the written application. To complete its review, the DHSIRB may
choose to rely solely on the written application, including attachments
submitted by the applicant.
(3)
Optional review of other information. In addition to its review of
the written application, including attachments, the DHSIRB may also choose to
invite:
(A) the primary investigator to
provide additional information;
(B)
subject matter experts to assist in the review; or
(C) experts and guests to attend the meeting
when the review takes place.
(4)
Review criteria. In order to
approve new research covered by this subsection, the DHSIRB determines, per
45 C.F.R. §
46.111 that the requirements in (A) through
(G) are satisfied.
(A) Risks to subjects are
minimized by using procedures:
(i) consistent
with sound research design and that do not unnecessarily expose subjects to
risk; and
(ii) already performed on
the subjects for diagnostic or treatment purposes, whenever
appropriate.
(B) Risks
are reasonable in relation to anticipated benefits to subjects, if any, and the
importance of the knowledge that may be expected to be gained. In evaluating
risks and benefits, DHSIRB considers only those risks and benefits that may
result from the research as distinguished from risks and benefits of therapies
subjects would receive even if not participating in the research. Per
45 C.F.R. §
46.111(a) (2), DHSIRB does
not consider possible long-range effects of applying the knowledge gained in
the research.
(C) Selection of
subjects is equitable. In making this assessment the DHSIRB takes into account
the research purposes and the setting in which the research is conducted.
Additionally, the DHSIRB is particularly cognizant of the special problems of
research involving subjects who are likely to be vulnerable to coercion or
undue influence, such as children, prisoners, economically or educationally
disadvantaged persons, or individuals with impaired decision-making
capacities.
(D) The proposed
research includes a plan to seek informed consent from each prospective
participant or the subject's legally authorized representative, per OAC
340:2-39-11.1.
(E) Informed consent is appropriately
documented or appropriately waived, per OAC
340:2-39-11.1.
(F) When appropriate, the research plan makes
adequate provision for monitoring the data collected to ensure the subjects'
safety.
(G) When appropriate, there
are adequate provisions to protect the subjects' privacy and maintain the
confidentiality of data.
(5)
Additional requirements. In
order to approve new research projects covered by this subsection the DHSIRB
reviews the investigator's qualifications to conduct and supervise the proposed
research. This process may include:
(A)
reviewing the investigators', sub-investigators', and other necessary research
staffs' resumes, verifying professional associations and licenses and may
include a review of the investigators' previous specific experience as
demonstrated by recent presentations or publications;
(B) using previous DHSIRB experience with the
investigators; and
(C) requesting
additional information confirming the investigators' qualifications from an
administrator of the investigators' institutions.